These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10200297)

  • 1. Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain.
    Mahoney MJ; Saltzman WM
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4536-9. PubMed ID: 10200297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of nerve growth factor following direct delivery to brain interstitium.
    Krewson CE; Klarman ML; Saltzman WM
    Brain Res; 1995 May; 680(1-2):196-206. PubMed ID: 7663977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport and elimination of recombinant human NGF during long-term delivery to the brain.
    Krewson CE; Saltzman WM
    Brain Res; 1996 Jul; 727(1-2):169-81. PubMed ID: 8842395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trophic effect of exogenous nerve growth factor on rat striatal cholinergic neurons: comparison between intraparenchymal and intraventricular administration.
    Venero JL; Hefti F; Knusel B
    Mol Pharmacol; 1996 Feb; 49(2):303-10. PubMed ID: 8632763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cholinergic pedunculopontine neurons in vitro: comparison with cholinergic septal cells and response to nerve growth factor, ciliary neuronotrophic factor, and retinoic acid.
    Knusel B; Hefti F
    J Neurosci Res; 1988; 21(2-4):365-75. PubMed ID: 3216429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intraventricular transplantation of NGF-secreting cells on cholinergic basal forebrain neurons after partial immunolesion.
    Rossner S; Yu J; Pizzo D; Werrbach-Perez K; Schliebs R; Bigl V; Perez-Polo JR
    J Neurosci Res; 1996 Jul; 45(1):40-56. PubMed ID: 8811511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.
    Knüsel B; Winslow JW; Rosenthal A; Burton LE; Seid DP; Nikolics K; Hefti F
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):961-5. PubMed ID: 1992488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of nerve growth factor in controlled release polymers and in tissue.
    Krewson CE; Dause R; Mak M; Saltzman WM
    J Biomater Sci Polym Ed; 1996; 8(2):103-17. PubMed ID: 8957707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of nerve growth factor from a polymeric implant.
    Powell EM; Sobarzo MR; Saltzman WM
    Brain Res; 1990 May; 515(1-2):309-11. PubMed ID: 2357568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats.
    Dixon CE; Flinn P; Bao J; Venya R; Hayes RL
    Exp Neurol; 1997 Aug; 146(2):479-90. PubMed ID: 9270059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of NGF secreting primary monocytes counteracts NMDA-induced cell death of rat cholinergic neurons in vivo.
    Zassler B; Humpel C
    Exp Neurol; 2006 Apr; 198(2):391-400. PubMed ID: 16443222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific brain protein changes correlated with behaviourally effective brain transplants.
    Wets KM; Sinden J; Hodges H; Allen Y; Marchbanks RM
    J Neurochem; 1991 Nov; 57(5):1661-70. PubMed ID: 1919581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates.
    Koliatsos VE; Clatterbuck RE; Nauta HJ; Knüsel B; Burton LE; Hefti FF; Mobley WC; Price DL
    Ann Neurol; 1991 Dec; 30(6):831-40. PubMed ID: 1789695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons.
    Cuello AC; Garofalo L; Kenigsberg RL; Maysinger D
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2056-60. PubMed ID: 2928318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-brain barrier penetration and in vivo activity of an NGF conjugate.
    Friden PM; Walus LR; Watson P; Doctrow SR; Kozarich JW; Bäckman C; Bergman H; Hoffer B; Bloom F; Granholm AC
    Science; 1993 Jan; 259(5093):373-7. PubMed ID: 8420006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocytes deliver bioactive nerve growth factor through a brain capillary endothelial cell-monolayer in vitro and counteract degeneration of cholinergic neurons.
    Böttger D; Ullrich C; Humpel C
    Brain Res; 2010 Feb; 1312():108-19. PubMed ID: 20004179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of young and aged rat CNS to partial cholinergic immunolesions and NGF treatment.
    Wörtwein G; Yu J; Toliver-Kinsky T; Perez-Polo JR
    J Neurosci Res; 1998 May; 52(3):322-33. PubMed ID: 9590440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined fetal neural transplantation and nerve growth factor infusion: effects on neurological outcome following fluid-percussion brain injury in the rat.
    Sinson G; Voddi M; McIntosh TK
    J Neurosurg; 1996 Apr; 84(4):655-62. PubMed ID: 8613859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly selective effects of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons.
    Koliatsos VE; Price DL; Gouras GK; Cayouette MH; Burton LE; Winslow JW
    J Comp Neurol; 1994 May; 343(2):247-62. PubMed ID: 8027442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism.
    Hellweg R; Nitsch R; Hock C; Jaksch M; Hoyer S
    J Neurosci Res; 1992 Mar; 31(3):479-86. PubMed ID: 1386388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.